These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8713279)

  • 21. Resistance of sandflies to DDT in Kala-azar endemic districts of Bihar, India.
    Singh R; Das RK; Sharma SK
    Bull World Health Organ; 2001; 79(8):793. PubMed ID: 11545338
    [No Abstract]   [Full Text] [Related]  

  • 22. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil.
    Lima Verde FA; Lima Verde FA; Lima Verde IA; Silva Junior GB; Daher EF; Lima Verde EM
    J Nephrol; 2007; 20(4):430-6. PubMed ID: 17879209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of kala-azar--an important stride.
    Sundar S
    J Assoc Physicians India; 2003 Aug; 51():753-5. PubMed ID: 14651132
    [No Abstract]   [Full Text] [Related]  

  • 25. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India.
    Boelaert M; Meheus F; Sanchez A; Singh SP; Vanlerberghe V; Picado A; Meessen B; Sundar S
    Trop Med Int Health; 2009 Jun; 14(6):639-44. PubMed ID: 19392741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with roxithromycin in visceral leishmaniasis in north Bihar.
    Lal SK; Lal R; Lal S; Lal R; Lal BN
    J Assoc Physicians India; 1996 Sep; 44(9):615-7. PubMed ID: 9251373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.
    Sundar S; Rai M; Chakravarty J; Agarwal D; Agrawal N; Vaillant M; Olliaro P; Murray HW
    Clin Infect Dis; 2008 Oct; 47(8):1000-6. PubMed ID: 18781879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visceral leishmaniasis (kala-azar)--the Bihar (India) perspective.
    Sinha PK; Ranjan A; Singh VP; Das VN; Pandey K; Kumar N; Verma N; Lal CS; Sur D; Manna B; Bhattacharya SK
    J Infect; 2006 Jul; 53(1):60-4. PubMed ID: 16269185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular typing of HLA class I and class II antigens in Indian kala-azar patients.
    Singh N; Sundar S; Williams F; Curran MD; Rastogi A; Agrawal S; Middleton D
    Trop Med Int Health; 1997 May; 2(5):468-71. PubMed ID: 9217702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kala-azar epidemic in Varanasi district, India.
    Kumar R; Kumar P; Chowdhary RK; Pai K; Mishra CP; Kumar K; Pandey HP; Singh VP; Sundar S
    Bull World Health Organ; 1999; 77(5):371-4. PubMed ID: 10361752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
    Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in blood protein spectrum in kala-azar].
    PERIANES J; PELAEZ JL; VAZQUEZ E
    Rev Clin Esp; 1958 Feb; 68(4):225-8. PubMed ID: 13555038
    [No Abstract]   [Full Text] [Related]  

  • 33. The blood in kala-azar.
    J Indian Med Assoc; 1970 Jun; 54(12):566. PubMed ID: 5503466
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on kala-azar. V. Atypical blood protein disorder].
    INFANTE MIRANDA F
    Rev Clin Esp; 1956 Aug; 62(4):251-4. PubMed ID: 13389948
    [No Abstract]   [Full Text] [Related]  

  • 35. Vectorial efficacy of Phlebotomus argentipes in Kala-azar endemic foci of Bihar (India) under natural and artificial conditions.
    Kumar V; Kishore K; Palit A; Keshari S; Sharma MC; Das VN; Shivakumar S; Roy MS; Sinha NK; Prasad M; Kar SK
    J Commun Dis; 2001 Jun; 33(2):102-9. PubMed ID: 12170928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kala-azar and platelets].
    SARROUY C; CABANNES R; SABATINI R; VAILLAUD
    Alger Medicale; 1960 Jun; 64():499-510. PubMed ID: 13746589
    [No Abstract]   [Full Text] [Related]  

  • 37. Coagulation studies in kala-azar: preliminary observations.
    Basu AK; Sen Gupta Sen PC; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1967 Apr; 15(2):45-6. PubMed ID: 5608916
    [No Abstract]   [Full Text] [Related]  

  • 38. [Contribution of leukoconcentration in the diagnosis of Kala-azar in Tunisia].
    Chemli J; Abroug M; Fathallah A; Abroug S; Ben Said M; Harbi A
    Med Mal Infect; 2006 Jul; 36(7):390-2. PubMed ID: 16872776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of serum proteins in kala-azar by filter paper electrophoresis.
    KUMAR S; KUMAR A; AGARWAL KL; MANGALIK VS
    J Indian Med Assoc; 1958 Jul; 31(1):14-7. PubMed ID: 13575838
    [No Abstract]   [Full Text] [Related]  

  • 40. Deficiency of fibrin stabilizing factor (FSF) in kala-azar.
    Basu AK; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1969 Apr; 17(2):35-6. PubMed ID: 5401878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.